Acutus Medical

AFIB · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0001

About AFIB

Acutus Medical, Inc. is an arrhythmia management company, which engages in improving the way cardiac arrhythmias are diagnosed and treated. The company is headquartered in Carlsbad, California and currently employs 85 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (i.e., the Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.

Employees
85
Headquarters
Carlsbad, California
Listed
Aug 6, 2020
Sector
Health Care
Industry
Health Care Equipment & Supplies

AFIB key statistics

Market cap
2.99K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.63K
Volume
61.95K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.014
52 Week low
$0.00

Acutus Medical (AFIB) at a glance

As of Oct 19, 2026, Acutus Medical (AFIB) shares are priced at $0.0001, giving the company a market cap of 2.99K and a price-to-earnings ratio of 0.00.

Volume so far is 61.95K shares, above the average of 4.63K shares a day.

Over the past year Acutus Medical has ranged from $0.00 to $0.014, and now sits 1% of the way up that range.

Acutus Medical met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY24 it reported -$0.01 per share against an estimate of -$0.4454.

AFIB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 57.6% on average.

  1. Q2 FY22: reported -$1.38 per share against an estimate of -$0.8119
  2. Q3 FY22: reported -$0.72 per share against an estimate of -$0.8242
  3. Q4 FY22: reported $0.41 per share against an estimate of -$0.7208
  4. Q1 FY23: reported -$0.57 per share against an estimate of -$0.7038
  5. Q2 FY23: reported -$0.63 per share against an estimate of -$0.6528
  6. Q3 FY23: reported -$0.45 per share against an estimate of -$0.6188
  7. Q1 FY24: reported -$0.07 per share against an estimate of -$0.5032
  8. Q2 FY24: reported -$0.01 per share against an estimate of -$0.4454

Similar companies

Companies in the same industry as Acutus Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.